Related Experiment Video
Updated: Mar 12, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Systemic Toxicity of Intraperitoneal Vancomycin
Teerath Kumar1, Iris Teo2, Brendan B McCormick1
1Division of Nephrology, Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Kidney Research Centre, University of Ottawa, Ottawa, ON, Canada.
Abstract:
Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patient who developed a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after three weeks of intraperitoneal vancomycin. We review the literature and conclude that this is the first ever reported case of DRESS syndrome from intraperitoneal vancomycin.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Risk factors
Drug toxicity: Idiosyncratic Reactions
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

